Share this post on:

Name :
MPDZ Polyclonal Antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
Polyclonal antibody to MPDZ

Tested applications :
WB, IHC

Species reactivity :
Human, Mouse, Rat

Alternative names :
MPDZ antibody; HYC2 antibody; MUPP1 antibody; multiple PDZ domain protein antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
Antigen: Recombinant fusion protein containing a sequence corresponding to amino acids 1100-1380 of human MPDZ (NP_003820.2).

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Storage instructions :
Store at -20℃. Avoid freeze / thaw cycles.

Applications :
WB 1:200 – 1:2000IHC 1:50 – 1:200

Background :
Interacts with HTR2C and provokes its clustering at the cell surface (By similarity). Member of the NMDAR signaling complex that may play a role in control of AMPAR potentiation and synaptic plasticity in excitatory synapses.

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Myc Rabbit mAb site
ERCC1 (YP6027) Mouse mAb MedChemExpress
Neomycin Antibody (YA907): Neomycin Antibody (YA907) is an unconjugated, rabbit-derived, anti-Neomycin (YA907) monoclonal antibody. Neomycin Antibody (YA907) can be used for: ELISA expriments in background without labeling.

Share this post on:

Author: Gardos- Channel